🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
The purpose of this study is to compare the effectiveness of daratumumab wh...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-23
Trial ID
NCT02076009
Treatments Being Tested
MyRisk: Efficacy and safety evaluation of oral Akynzeo® in patients receivi...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2021-02-01
Trial ID
NCT04817189
This is a phase 1/2 multicenter, open-label umbrella platform study that wi...
Status
Recruiting
Location
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927)
Start Date
2024-08-07
Trial ID
NCT06445972
Treatments Being Tested
This is a phase II, open-label, multicenter, pilot study of the safety and ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00446030
Treatments Being Tested
The goal of this project is to rapidly screen promising agents, in the sett...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-07-31
Trial ID
NCT04488081
A Phase 2 study investigating the addition of cRIT 131I-omburtamab to irino...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-04-04
Trial ID
NCT04743661
The purpose of this study is to see if the combination of bendamustine, len...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2008-02
Trial ID
NCT01042704